Njord Medtech

Njord Medtech is driven by the motto that knowing is not enough. We must act. By applying an innovation-centric approach targeting hospital stakeholders we strive to create a satisfying and value-driven healthcare system for the many.

Together with our partners and healthcare professionals we continuously explore and evaluate need areas for which new technologies and products can be applied to solve the problems of today and tomorrow.

In a short-term perspective Njord targets to increase value throughput at Radiology departments with a patented motorized device – Atle® 180. Additionally, a new solution to facilitate supine to prone position improving patient oxygenation is under development.

Nyheter

LSI Epsilon invest in AAX Biotech.

LSI Epsilon invest in AAX Biotech.

Say hi to AAX Biotech AB! ✨ It is with excitement and joy we present LSI Epsilon's third investment. AAX Biotech is a Swedish biotech company enabling and accelerating the development of highly effective antibody-based medicines. We look forward to work with Maria...

läs mer
LSI Epsilon invest in Key2Brain.

LSI Epsilon invest in Key2Brain.

Hello Key2Brain AB! ✨ It is with great pleasure that we can present LSI Epsilon's second investment. Key2Brain is a Swedish biotechnology company developing a novel and efficacious brain targeting platform technology. We look forward to work with Elisabet Sjöström,...

läs mer
MyCural wins the Nordic Star Award

MyCural wins the Nordic Star Award

Our portfolio company MyCural Therapeutics has won the Nordic Star 2024 Award at Nordic Life Science Days. So well deserved Alina Castell and team, you are fantastic. Thank you Innovestor, Johnson & Johnson and SwedenBIO for organising the prise.

läs mer